PULEO, LUCIANA Statistiche

PULEO, LUCIANA  

DIPARTIMENTO DI MEDICINA CLINICA E SPERIMENTALE  

Mostra records
Risultati 1 - 16 di 16 (tempo di esecuzione: 0.031 secondi).
Titolo Data di pubblicazione Autore(i) File
Active surveillance in differentiated thyroid cancer: a strategy applicable to all treatment categories response 1-gen-2023 Campopiano, Maria Cristina; Ghirri, Arianna; Prete, Alessandro; Lorusso, Loredana; Puleo, Luciana; Cappagli, Virginia; Agate, Laura; Bottici, Valeria; Brogioni, Sandra; Gambale, Carla; Minaldi, Elisa; Matrone, Antonio; Elisei, Rossella; Molinaro, Eleonora
Yttrium-90 transarterial radioembolization for liver metastases from medullary thyroid cancer 1-gen-2022 Puleo, Luciana; Agate, Laura; Bargellini, Irene; Boni, Giuseppe; Piaggi, Paolo; Traino, Claudio; Depalo, Tommaso; Lorenzoni, Giulia; Bianchi, Francesca; Volterrani, Duccio; Brogioni, Sandra; Bottici, Valeria; Brunetto, Maurizia Rossana; Coco, Barbara; Molinaro, Eleonora; Elisei, Rossella
FDG-PET/CT Correlates with the Response of Radiorefractory Thyroid Cancer to Lenvatinib and Patient Survival 1-gen-2021 Valerio, L.; Guidoccio, F.; Giani, C.; Tardelli, E.; Puccini, G.; Puleo, L.; Minaldi, E.; Boni, G.; Elisei, R.; Volterrani, D.
Prevalence and Risk Factors of Developing Fistula or Organ Perforation in Patients Treated with Lenvatinib for Radioiodine-Refractory Thyroid Cancer 1-gen-2021 Valerio, L.; Giani, C.; Agate, L.; Molinaro, E.; Viola, D.; Bottici, V.; Matrone, A.; Puleo, L.; Lorusso, L.; Cappagli, V.; Ribechini, A.; Elisei, R.
Thyroid cancers: From surgery to current and future systemic therapies through their molecular identities 1-gen-2021 Lorusso, L.; Cappagli, V.; Valerio, L.; Giani, C.; Viola, D.; Puleo, L.; Gambale, C.; Minaldi, E.; Campopiano, M. C.; Matrone, A.; Bottici, V.; Agate, L.; Molinaro, E.; Elisei, R.
Active surveillance in papillary thyroid microcarcinomas is feasible and safe: experience at one single Italian center 1-gen-2020 Molinaro, Eleonora; Campopiano, Maria Cristina; Pieruzzi, Letizia; Matrone, Antonio; Agate, Laura; Bottici, Valeria; Viola, David; Cappagli, Virginia; Valerio, Laura; Giani, Carlotta; Puleo, Luciana; Lorusso, Loredana; Piaggi, Paolo; Torregrossa, Liborio; Basolo, Fulvio; Vitti, Paolo; Tuttle, R Michael; Elisei, Rossella
MON-490 Calcitonin-Based Thyroidectomy Is a Safe Approach in Patients with Germline RET Mutation and Permits to Delay Surgery in Children 1-gen-2020 Prete, A; Romei, C; Tacito, A; Ramone, T; Bottici, V; Cappagli, V; Viola, D; Matrone, A; Agate, L; Lorusso, L; Valerio, L; Giani, C; Puleo, L; Molinaro, E; Elisei, R.
No difference in the outcome of metastatic thyroid cancer patients when using recombinant or endogenous TSH 1-gen-2020 Campopiano, Maria Cristina; Podestà, Debora; Bianchi, Francesca; Giani, Carlotta; Agate, Laura; Bottici, Valeria; Cappagli, Virginia; Lorusso, Loredana; Matrone, Antonio; Puleo, Luciana; Valerio, Laura; Viola, David; Piaggi, Paolo; Elisei, Rossella; Molinaro, Eleonora
Re: "Symptomatic Biliary Disorders During Lenvatinib Treatment for Thyroid Cancer: An Underestimated Problem" by Nervo et al 1-gen-2020 Agate, Laura; Puleo, Luciana; Giani, Carlotta; Valerio, Laura; Molinaro, Eleonora; Elisei, Rossella
A rare adverse event (AE) in a group of radioiodine-refractory differentiated thyroid cancer (RAI-R DTC) patients in therapy with lenvatinib. 1-gen-2019 Puleo, Luciana; Giani, Carlotta; Valerio, Laura; Viola, David; Molinaro, Eleonora; Elisei, Rossella; Agate, Laura
Hypertension, nausea, anorexia and weight loss were significantly associated with better progression-free survival in patients with radioiodine-Refractory Differentiated Thyroid Carcinoma treated with Lenvatinib 1-gen-2018 Giani, C.; Valerio, L.; Pieruzzi, L.; Agate, L.; Viola, D.; Bottici, V.; Piaggi, P.; Lorusso, L.; Cappagli, V.; Puleo, L.; Matrone, A.; Mazzeo, S.; Ribechini, A.; Vitti, P.; Molinaro, E.; Elisei, Rossella
Lenvatinib therapy in progressive, radioiodine-refractory, differentiated thyroid carcinoma: analysis of 74 cases followed in a single centre 1-gen-2018 Giani, C; Valerio, L; Pieruzzi, L; Agate, L; Viola, D; Bottici, V; Piaggi, P; Lorusso, L; Cappagli, V; Puleo, L; Matrone, A; Mazzeo, S; Pontillo-Contillo, B; Ribechini, A; Vitti, P; Molinaro, E; Elisei, R.
Targeted Therapy in Thyroid Cancer: State of the Art 1-gen-2017 Valerio, Laura; Pieruzzi, Letizia; Giani, Carlotta; Agate, Laura; Bottici, Valeria; Lorusso, Loredana; Cappagli, Virginia; Puleo, Luciana; Matrone, Antonio; Viola, David; Romei, Cristina; Ciampi, Raffaele; Molinaro, Eleonora; Elisei, Rossella
Correlation Between The Presence Of Macrophages And Braf V600e Mutation In Different Variants Of Well Differentiated Papillary Thyroid Cancer 1-gen-2016 Puleo, Luciana; Ugolini, Clara; Viola, David; Molinaro, Eleonora; Agate, Laura; Matrone, Antonio; Basolo, Fulvio; Vitti, Paolo; Elisei, Rossella; Romei, Cristina
Treatment of advanced thyroid cancer with targeted therapies: Ten years of experience 1-gen-2016 Viola, David; Valerio, Laura; Molinaro, Eleonora; Agate, Laura; Bottici, Valeria; Biagini, Agnese; Lorusso, Loredana; Cappagli, Virginia; Pieruzzi, Letizia; Giani, Carlotta; Sabini, Elena; Passannati, Paolo; Puleo, Luciana; Matrone, Antonio; PONTILLO CONTILLO, Benedetta; Battaglia, Valentina; Mazzeo, Salvatore; Vitti, Paolo; Elisei, Rossella
Follicular (FVPTC) VS Classical (CVPTC) variant of papillary thyroid cancer: correlation of the outcome after 12 years of follow up. 1-gen-2014 Giani, C; Torregrossa, L; Molinaro, E; Cacciato Insilla, A; Agate, L; Viola, D; Puleo, L; Materazzi, G; Marchetti, I; Miccoli, P; Di Coscio, G; Vitti, P; Basolo, F; Elisei, R.